SSR240612 is primarily utilized in research settings to study its effects on the bradykinin B1 receptor, which plays a role in inflammation and pain pathways. It acts as a selective antagonist, helping researchers understand the receptor's function in various physiological and pathological conditions. This compound is particularly valuable in exploring potential therapeutic strategies for inflammatory diseases, neuropathic pain, and other conditions where the bradykinin B1 receptor is implicated. Its application extends to preclinical studies aimed at developing novel treatments targeting this receptor.